(Q34727547)

4 August 2017

1 reference

title

Antioxidant neuroprotection in Alzheimer's disease as preventive and therapeutic approach (English)

1 reference

4 August 2017

0 references

Christian Behl

1

1 reference

PubMed ID

12106814

4 August 2017

Bernd Moosmann

series ordinal

2

1 reference

4 August 2017

1 July 2002

1 reference

Free Radical Biology and Medicine

4 August 2017

1 reference

4 August 2017

33

1 reference

4 August 2017

2

1 reference

4 August 2017

182-191

1 reference

Biochemistry of Oxidative Stress

4 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900883-3

7 January 2021

Strategies of antioxidant defense

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900883-3

7 January 2021

Oxidants, oxidative stress and the biology of ageing

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900883-3

7 January 2021

Antioxidants in human health and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900883-3

7 January 2021

The role of oxidative stress in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900883-3

7 January 2021

Oxidative stress and Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900883-3

7 January 2021

Aging, energy, and oxidative stress in neurodegenerative diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900883-3

7 January 2021

Alzheimer's disease and oxidative stress: implications for novel therapeutic approaches

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900883-3

7 January 2021

Aging: phenomena and theories

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900883-3

7 January 2021

Hydrogen peroxide mediates amyloid beta protein toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900883-3

7 January 2021

Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900883-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900883-3

1 reference

7 January 2021

Alzheimer's disease: genes, proteins, and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900883-3

7 January 2021

Mechanisms of neuronal degeneration in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900883-3

7 January 2021

Amyloid beta-protein toxicity and oxidative stress in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900883-3

7 January 2021

Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900883-3

7 January 2021

Amyloid and Alzheimer's disease--cause or effect?

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900883-3

7 January 2021

RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900883-3

7 January 2021

Beta amyloid toxicity does not require RAGE protein

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900883-3

7 January 2021

Mechanisms of neurodegenerative disorders: Part 2: control of cell death.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900883-3

7 January 2021

Aging renders the brain vulnerable to amyloid beta-protein neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900883-3

7 January 2021

Glucocorticoids enhance oxidative stress-induced cell death in hippocampal neurons in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900883-3

7 January 2021

Neuroprotection against oxidative stress by estrogens: structure-activity relationship

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900883-3

7 January 2021

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900883-3

7 January 2021

A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900883-3

7 January 2021

A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900883-3

7 January 2021

Beta-secretase revealed: starting gate for race to novel therapies for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900883-3

7 January 2021

The role of anti-inflammatory drugs in the prevention and treatment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900883-3

7 January 2021

Vitamin E protects nerve cells from amyloid beta protein toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900883-3

7 January 2021

Direct evidence of oxidative injury produced by the Alzheimer's beta-amyloid peptide (1-40) in cultured hippocampal neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900883-3

7 January 2021

A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900883-3

7 January 2021

17-beta estradiol protects neurons from oxidative stress-induced cell death in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900883-3

7 January 2021

The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900883-3

7 January 2021

Novel and potent biological antioxidants on membrane phospholipid peroxidation: 2-hydroxy estrone and 2-hydroxy estradiol

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900883-3

7 January 2021

Estrogens as natural antioxidants of membrane phospholipid peroxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900883-3

7 January 2021

Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid beta-peptide toxicity in hippocampal neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900883-3

7 January 2021

17 alpha-estradiol exerts neuroprotective effects on SK-N-SH cells

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900883-3

7 January 2021

Scavestrogens protect IMR 32 cells from oxidative stress-induced cell death.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900883-3

7 January 2021

Induction of reactive oxygen species in neurons by haloperidol.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900883-3

7 January 2021

Estradiol protects against ischemic injury

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900883-3

7 January 2021

Estrogen provides neuroprotection in transient forebrain ischemia through perfusion-independent mechanisms in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900883-3

7 January 2021

Neuroprotective effects of estrogens: potential mechanisms of action

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900883-3

7 January 2021

Neuroprotective potential of aromatic alcohols against oxidative cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900883-3

7 January 2021

Quercetin protects cutaneous tissue-associated cell types including sensory neurons from oxidative stress induced by glutathione depletion: cooperative effects of ascorbic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900883-3

7 January 2021

Low concentrations of estradiol reduce beta-amyloid (25-35)-induced toxicity, lipid peroxidation and glucose utilization in human SK-N-SH neuroblastoma cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900883-3

7 January 2021

Blood-brain barrier permeation: molecular parameters governing passive diffusion

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900883-3

7 January 2021

Estrogen actions in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900883-3

7 January 2021

Estrogen replacement therapy in older women. Comparisons between Alzheimer's disease cases and nondemented control subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900883-3

7 January 2021

Oestrogens and dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900883-3

7 January 2021

Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900883-3

7 January 2021

Neuroprotective properties of cannabinoids against oxidative stress: role of the cannabinoid receptor CB1.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900883-3

7 January 2021

Protective activity of aromatic amines and imines against oxidative nerve cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900883-3

7 January 2021

Cytoprotective antioxidant function of tyrosine and tryptophan residues in transmembrane proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900883-3

7 January 2021

Multiple antioxidants in the prevention and treatment of Alzheimer disease: analysis of biologic rationale

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900883-3

7 January 2021

Copernicus revisited: amyloid beta in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900883-3

7 January 2021

Neuronal oxidative stress precedes amyloid-beta deposition in Down syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900883-3

7 January 2021

Oxidative damage is the earliest event in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900883-3

7 January 2021

Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900883-3

7 January 2021

Genes, models and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900883-3

7 January 2021

Alzheimer disease: mouse models pave the way for therapeutic opportunities

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900883-3

7 January 2021

Vitamin E and Alzheimer disease: the basis for additional clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900883-3

7 January 2021

A 1-year controlled trial of acetyl-l-carnitine in early-onset AD.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900883-3

7 January 2021

A controlled study of 2 doses of idebenone in the treatment of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900883-3

7 January 2021

Sustained efficacy and safety of idebenone in the treatment of Alzheimer's disease: update on a 2-year double-blind multicentre study

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900883-3

7 January 2021

Protective effects of idebenone and alpha-tocopherol on beta-amyloid-(1-42)-induced learning and memory deficits in rats: implication of oxidative stress in beta-amyloid-induced neurotoxicity in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900883-3

7 January 2021

Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900883-3

7 January 2021

Iron accumulation in Alzheimer disease is a source of redox-generated free radicals

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900883-3

7 January 2021

Cu(II) potentiation of alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900883-3

7 January 2021

Chemistry and biochemistry of oxidative stress in neurodegenerative disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900883-3

7 January 2021

Intramuscular desferrioxamine in patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900883-3

7 January 2021

The cognition-enhancing drug tenilsetam is an inhibitor of protein crosslinking by advanced glycosylation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900883-3

7 January 2021

beta-Amyloid toxicity in organotypic hippocampal cultures: protection by EUK-8, a synthetic catalytic free radical scavenger

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900883-3

7 January 2021

The pathogenesis of Alzheimer's disease. Is amyloid beta-protein the beginning or the end?

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900883-3

7 January 2021

Alzheimer disease: protective factors

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900883-3

7 January 2021

Alpha tocopherol in CSF of subjects taking high-dose vitamin E in the DATATOP study. Parkinson Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900883-3

7 January 2021

Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900883-3

7 January 2021

10.1016/S0891-5849(02)00883-3

Identifiers

DOI

1 reference

4 August 2017

1 reference

PubMed ID

12106814